Nutritional therapies in Parkinson's disease

被引:8
作者
Evatt M.L. [1 ]
机构
[1] Department of Neurology, Movement Disorders Section, Emory University School of Medicine, Atlanta, GA 30329
关键词
Levodopa; Percutaneous Endoscopic Gastrostomy; Motor Fluctuation; Tegaserod; Recommend Dietary Allowance;
D O I
10.1007/BF02938409
中图分类号
学科分类号
摘要
Advise patients with Parkinson's disease (PD) to consume a balanced diet, with special attention to adequate intake of dietary fiber, fluids, and macro- and micronutrients. Regularly reassess patients' nutritional history and anthropomorphic measures (height and weight), particularly in patients with advanced disease. PD-related psychosocial as well as physical and cognitive limitations increase susceptibility to subacute and chronic malnutrition. Nutritional requirements may change with PD progression or after surgical therapy for PD. Patients and caregivers may benefit from counseling by a dietician who is knowledgeable about the nutritional risks and needs of PD. Regularly inquire about dysphagia symptoms, and consider speech therapy consultation for clinical and modified barium-swallowing evaluations and management recommendations. Although non-oral delivery options of dopaminergic therapy are increasing, severe dysphagia may warrant percutaneous endoscopic gastrostomy tube placement for nutritional support and more reliable PD medication dosing. Analyze vitamin B12 and D concentrations at regular intervals. Both vitamins are frequently deficient in elderly persons but may not be routinely checked by primary care physicians. Record over-the-counter and nutritional supplement medications at each visit, and assist patients in periodically re-evaluating their potential benefits, side effects, drug interactions, and costs. To date, clinical trials of antioxidant vitamins and nutritional supplements have provided insufficient evidence to support routine use for PD in the clinic. Data from several clinical trials of antioxidant vitamins/nutritional supplements are expected in the near future. Consider altering medication dosing in relation to meals to help with mild to moderate motor fluctuations. Patients with severe motor fluctuations may benefit from adapting the 5:1 carbohydrate-to-protein ratio in their daily meals and snacks. Following a "protein redistribution" diet is logistically more difficult and less palatable, and therefore less frequently recommended. To ensure adequate protein intake, a registered dietician should supervise patients who follow either of these diets. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:198 / 204
页数:6
相关论文
共 56 条
[1]  
Savitt J.M., Dawson V.L., Dawson T.M., Diagnosis and treatment of Parkinson disease: Molecules to medicine, J Clin Invest, 116, pp. 1744-1754, (2006)
[2]  
Olanow C.W., Jankovic J., Neuroprotective therapy in Parkinson's disease and motor complications: A search for a pathogenesis-targeted, disease-modifying strategy, Mov Disord, 20, SUPPL. 11, (2005)
[3]  
VanItallie T.B., Nonas C., Di Rocco A., Et al., Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study, Neurology, 64, pp. 728-730, (2005)
[4]  
Apaydin H., Ertan S., Ozekmekci S., Broad bean (Vicia faba) - a natural source of L-dopa - prolongs "on" periods in patients with Parkinson's disease who have "on-off" fluctuations, Mov Disord, 15, pp. 164-166, (2000)
[5]  
Rabey J.M., Vered Y., Shabtai H., Et al., Broad bean (Vicia faba) consumption and Parkinson's disease, Adv Neurol, 60, pp. 681-684, (1993)
[6]  
Rabey J.M., Vered Y., Shabtai H., Et al., Improvement of parkinsonian features correlates with high plasma levodopa values after broad bean (Vicia faba) consumption, J Neurol Neurosurg Psychiatry, 55, pp. 725-727, (1992)
[7]  
Ladha S.S., Walker R., Shill H.A., Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance, Mov Disord, 20, pp. 630-631, (2005)
[8]  
Manyam B.V., Sanchez-Ramos J.R., Traditional and complementary therapies in Parkinson's disease, Adv Neurol, 80, pp. 565-574, (1999)
[9]  
Katzenschlager R., Evans A., Manson A., Et al., Mucuna pruriens in Parkinson's disease: A double blind clinical and pharmacological study, J Neurol Neurosurg Psychiatry, 75, pp. 1672-1677, (2004)
[10]  
Mena I., Cotzias G.C., Protein intake and treatment of Parkinson's disease with levodopa, N Engl J Med, 292, pp. 181-184, (1975)